A CHARITY which represents people with MS has criticised a decision to deny approval of a new drug for treating the condition. The National Institute for Health and Care Excellence (NICE) - the regulator which approves new treatments and drugs for use by the NHS in England and Wales - has provisionally decided not to recommend ozanimod a new, oral treatment for people with relapsing MS . The treatment would have been used to help those with relapsing multiple sclerosis Continue reading →

Linda Glassel Jan. 31, 2021Updated: Jan. Continue reading →

A common belief is that women with schizophrenia have a more favorable disease course and overall outcomes than men.1 However, previous studies of sex-outcome differences in patients with first-episode psychosis (FEP) have produced mixed results. Furthermore, there is an indication that, in general, short- and long-term outcomes in schizophrenia may differ.2,3 No previous studies have specifically explored long-term sex differences in patients with FEP after being discharged from a psychosis early intervention service (EIS). Continue reading →

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces the appointment of Susanne L. Meline to its Board of Directors, effective January 31, 2021 Continue reading →

Our hopes have been dashed so many times by miracle cures touted for COVID-19, so on September 25, when President Nicols Maduro of Venezuela promoted one with no scientific evidence whatsoever to back it up, nobody could blame the research community for being just a bit skeptical. Of course, we all remember hydroxychloroquine, the anti-malaria drug pushed by former U.S. Continue reading →

We need to throw the book at them, Rep. Ruben Gallego, an Arizona Democrat and former Marine infantryman, told CNN, regarding the service members and veterans involved in the Jan. 6 assault on the Capitol. Continue reading →

February 02, 2021 08:00 ET | Source: Protara Therapeutics NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc.(Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced the appointment of Cynthia Smith to its Board of Directors Continue reading →

February 02, 2021 08:00 ET | Source: Gain Therapeutics BETHESDA, Md., Feb. Continue reading →